Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,335,722
+$106,233 QoQ
Shares Held
9,282
-9.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#1,848
of 4,153 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILDRESS CAPITAL ADVISORS, LLC holds $17,780,353 across 10 Drug Manufacturers - General names. ABBV ranks #4 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,947 | $4,050,059 | |
| 2 | LLY |
ELI LILLY & Co
|
3,245 | $3,892,150 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,037 | $2,703,254 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,282 | $2,335,722 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,874 | $1,752,841 | |
| 6 | AMGN |
Amgen Inc
|
3,488 | $1,263,074 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,974 | $747,561 | |
| 8 | PFE |
Pfizer Inc
|
21,776 | $524,366 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,335,722 | 9,282 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,229,489 | 10,251 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,451,240 | 10,728 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,243,159 | 9,688 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,542,502 | 8,310 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,391,841 | 6,643 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,164,645 | 6,554 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,307,910 | 6,623 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,115,223 | 6,502 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,158,884 | 6,364 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,058,445 | 6,830 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $980,665 | 6,579 | Shares | Sole | 2023-11-06 | |
| 2023-03-31 | $338,342 | 2,123 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,155,026 | 7,147 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $887,933 | 6,616 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,045,470 | 6,826 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,059,064 | 6,533 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $867,643 | 6,408 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $869,755 | 8,063 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $467,456 | 4,150 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $850,717 | 7,861 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $571,752 | 5,336 | Shares | Sole | 2021-03-09 | |
| No filing history on record for this holder in this stock. | ||||||